Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.24.2.u1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Class A Common Stock
Common Stock
Class A Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance (in shares) at Dec. 29, 2022     106,151,000      
Beginning balance at Dec. 29, 2022 $ 1,657,176   $ 106 $ 482,312 $ 4,337 $ 1,170,421
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 6,741     6,741    
Exercise of stock options (in shares)     79,000      
Exercise of stock options 2,130     2,130    
Issuance of common stock upon vesting of restricted stock units (in shares)     117,000      
Shares issued under employee stock purchase plan (in shares)     43,000      
Shares issued under employee stock purchase plan 2,558     2,558    
Common stock redeemed for tax liability (in shares)     (119,000)      
Common stock redeemed for tax liability (10,863)     (10,863)    
Other comprehensive loss, net of tax (849)       (849)  
Net income 71,524         71,524
Ending balance (in shares) at Mar. 30, 2023     106,271,000      
Ending balance at Mar. 30, 2023 1,728,417   $ 106 482,878 3,488 1,241,945
Beginning balance (in shares) at Dec. 29, 2022     106,151,000      
Beginning balance at Dec. 29, 2022 1,657,176   $ 106 482,312 4,337 1,170,421
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive loss, net of tax (975)          
Net income 142,976          
Ending balance (in shares) at Jun. 29, 2023     106,391,000      
Ending balance at Jun. 29, 2023 1,809,779   $ 106 492,914 3,362 1,313,397
Beginning balance (in shares) at Mar. 30, 2023     106,271,000      
Beginning balance at Mar. 30, 2023 1,728,417   $ 106 482,878 3,488 1,241,945
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 8,306     8,306    
Exercise of stock options (in shares)     123,000      
Exercise of stock options 2,728     2,728    
Issuance of common stock upon vesting of restricted stock units (in shares)     8,000      
Common stock redeemed for tax liability (in shares)     (11,000)      
Common stock redeemed for tax liability (998)     (998)    
Other comprehensive loss, net of tax (126)       (126)  
Net income 71,452         71,452
Ending balance (in shares) at Jun. 29, 2023     106,391,000      
Ending balance at Jun. 29, 2023 1,809,779   $ 106 492,914 3,362 1,313,397
Beginning balance (in shares) at Dec. 28, 2023   106,737,532 106,738,000      
Beginning balance at Dec. 28, 2023 1,930,990   $ 107 513,060 1,422 1,416,401
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 7,232     7,232    
Exercise of stock options (in shares)     171,000      
Exercise of stock options 3,854     3,854    
Issuance of common stock upon vesting of restricted stock units (in shares)     184,000      
Shares issued under employee stock purchase plan (in shares)     28,000      
Shares issued under employee stock purchase plan 2,720     2,720    
Common stock redeemed for tax liability (in shares)     (110,000)      
Common stock redeemed for tax liability (13,057)     (13,057)    
Other comprehensive loss, net of tax (970)       (970)  
Net income 50,032         50,032
Ending balance (in shares) at Mar. 28, 2024     107,011,000      
Ending balance at Mar. 28, 2024 1,980,801   $ 107 513,809 452 1,466,433
Beginning balance (in shares) at Dec. 28, 2023   106,737,532 106,738,000      
Beginning balance at Dec. 28, 2023 $ 1,930,990   $ 107 513,060 1,422 1,416,401
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares) 283,357          
Other comprehensive loss, net of tax $ (1,316)          
Net income 106,698          
Ending balance (in shares) at Jun. 27, 2024   107,132,849 107,133,000      
Ending balance at Jun. 27, 2024 2,046,594   $ 107 523,282 106 1,523,099
Beginning balance (in shares) at Mar. 28, 2024     107,011,000      
Beginning balance at Mar. 28, 2024 1,980,801   $ 107 513,809 452 1,466,433
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 8,355     8,355    
Exercise of stock options (in shares)     112,000      
Exercise of stock options 1,588     1,588    
Issuance of common stock upon vesting of restricted stock units (in shares)     13,000      
Common stock redeemed for tax liability (in shares)     (3,000)      
Common stock redeemed for tax liability (470)     (470)    
Other comprehensive loss, net of tax (346)       (346)  
Net income 56,666         56,666
Ending balance (in shares) at Jun. 27, 2024   107,132,849 107,133,000      
Ending balance at Jun. 27, 2024 $ 2,046,594   $ 107 $ 523,282 $ 106 $ 1,523,099